The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study
Circulation · 2025
DOI: 10.1161/circulationaha.124.072961 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation, 2025. Verfasst von Kurt R Schumacher und 24 weiteren Autor:innen. Beteiligte Einrichtung: Congenital Heart Center, Department of Pediatrics, University of Michigan, Ann Arbor (K.R.S., A.B., S.Y., G.R., M.K.C.). Hauptthemen laut MEDLINE: Heart Transplantation, Fontan Procedure, Heart Failure, Heart Defects, Congenital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ disease, and need for heart transplant. Specific FCF morbidities have not been rigorously defined, limiting study of how FCF morbidities affect pre–heart transplant and post–heart transplant outcomes. We hypothesized that FCF-related morbidities affect survival from heart transplant waitlisting through 1 year after heart transplant. METHODS: This 20-center, retrospective cohort study collected demographic, medical/surgical history, waitlist, and peri- and post–heart transplant data, and a priori defined FCF-specific morbidities, in Fontan patients who were listed for heart transplant from 2008 through 2022. Univariate 2-group statistics compared surviving individuals with those who died anytime from waitlisting to 1 year after heart transplant, died on the waitlist, or underwent transplant and died within 1 year after transplant. Using covariates from both univariate analyses, multivariable logistic regression determined the primary study outcome of independent FCF risk factors for death between waitlist and 1 year after heart transplant. RESULTS: Of 409 waitlisted patients, 24 (5.9%) died on the waitlist. Of the 341 (83.4%) who underwent transplant, 27 (8.5%) did not survive to 1 year. Univariate risk factors for waitlist death included higher aortopulmonary collateral burden, >1 hospitalization in the previous year, younger age, sleep apnea, higher New York Heart Association class, nonenrollment in school or work, and single-parent home. Risk factors for 1-year post–heart transplant mortality included hypoplastic left heart syndrome diagnosis, patent fenestration, anatomic Fontan obstruction, clinical cyanosis (pulse oximetry 1 hospitalization in the year before waitlisting (adjusted odds ratio, 2.0 [95% CI, 1.0–4.1]; P =0.05) and clinical cyanosis (adjusted odds ratio, 5.0 [95% CI, 1.8–13.4]; P =0.002). CONCLUSIONS: Patients with Fontan palliation selected for heart transplant have substantial mortality rates from waitlisting through transplant. Among FCF-specific morbidities, cyanosis is associated with worsened survival and necessitates further study. Clinical morbidity of any type requiring repeated hospital admission also should prompt consideration of heart transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Congenital Heart Center, Department of Pediatrics, University of Michigan, Ann Arbor (K.R.S., A.B., S.Y., G.R., M.K.C.).
- Department of Pediatrics, Stanford University, Palo Alto, CA (D.N.R.).
- Department of Pediatrics, Division of Cardiology, Children's Health, UT Southwestern, Dallas, TX (M.B.).
- Pediatric Cardiology, Children's National Hospital, George Washington University, Washington, DC (S.R.D.).
- The Children's Hospital of Philadelphia, PA (M.O., H.A.).
- Department of Pediatrics, University of Utah, Salt Lake City (S.C., M.P.).
ORCID-Profile: Kurt R Schumacher, David N Rosenthal, Adriana Batazzi, Sunkyung Yu, Garrett Reichle, Maria Bano, Shriprasad R Deshpande, Matthew O'Connor, Humera Ahmed, Lydia K Wright, Steven J Kindel, Anna Joong, Brian Feingold, Chad Y Mao, Kathleen E Simpson, Aecha Ybarra, Marc E Richmond, Shahnawaz Amdani, Jennifer Conway, Elizabeth D Blume, Melissa K Cousino
Zitieren
APA
Schumacher, K. R., Rosenthal, D. N., Batazzi, A., Yu, S., Reichle, G., Bano, M., Deshpande, S. R., O'Connor, M., Ahmed, H., Chen, S., Wright, L. K., Kindel, S. J., Joong, A., Ploutz, M., Feingold, B., Godown, J., Mao, C. Y., Lorts, A., Simpson, K. E., …, & Cousino, M. K. (2025). The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study. Circulation. https://doi.org/10.1161/circulationaha.124.072961
Vancouver
Schumacher KR, Rosenthal DN, Batazzi A, Yu S, Reichle G, Bano M, et al. The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study. Circulation. 2025. doi:10.1161/circulationaha.124.072961
BibTeX
@article{Schumacher2025,
author = {Schumacher, Kurt R and Rosenthal, David N and Batazzi, Adriana and Yu, Sunkyung and Reichle, Garrett and Bano, Maria and Deshpande, Shriprasad R and O'Connor, Matthew and Ahmed, Humera and Chen, Sharon and Wright, Lydia K and Kindel, Steven J and Joong, Anna and Ploutz, Michelle and Feingold, Brian and Godown, Justin and Mao, Chad Y and Lorts, Angela and Simpson, Kathleen E and Ybarra, Aecha and Richmond, Marc E and Amdani, Shahnawaz and Conway, Jennifer and Blume, Elizabeth D and Cousino, Melissa K},
title = {The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study},
journal = {Circulation},
year = {2025},
doi = {10.1161/circulationaha.124.072961}
}
EUVIMED